摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2'S,4'R)-methyl 1'-((S)-2-tert-butoxycarbonyl)amino-4-methylpentanoyl-4'-hydroxypyrrolidine-2'-carboxylate | 934552-55-3

中文名称
——
中文别名
——
英文名称
(2'S,4'R)-methyl 1'-((S)-2-tert-butoxycarbonyl)amino-4-methylpentanoyl-4'-hydroxypyrrolidine-2'-carboxylate
英文别名
N-[N-(tert-butyloxycarbonyl)-L-leucyl]-4R-hydroxy-L-proline methyl ester;Boc-Leu-Hyp-OMe
(2'S,4'R)-methyl 1'-((S)-2-tert-butoxycarbonyl)amino-4-methylpentanoyl-4'-hydroxypyrrolidine-2'-carboxylate化学式
CAS
934552-55-3
化学式
C17H30N2O6
mdl
——
分子量
358.435
InChiKey
BQXYJVLTJCFBLD-AGIUHOORSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.06
  • 重原子数:
    25.0
  • 可旋转键数:
    5.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.82
  • 拓扑面积:
    105.17
  • 氢给体数:
    2.0
  • 氢受体数:
    6.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (2'S,4'R)-methyl 1'-((S)-2-tert-butoxycarbonyl)amino-4-methylpentanoyl-4'-hydroxypyrrolidine-2'-carboxylate乙酰氯三乙胺 作用下, 以 甲醇甲苯 为溶剂, 反应 18.0h, 以78%的产率得到3-异丁基-8-羟基六氢吡咯并[1,2-A]吡嗪-1,4-二酮
    参考文献:
    名称:
    通过定制化单元的选择性修饰合成具有定制N和α链的二酮哌嗪支架
    摘要:
    在DKP基板中对Hyp可定制单元的选择性操作允许生成具有四个空间定向的量身定制链的刚性支架。关键步骤是多米诺骨牌断裂-氧化过程,该过程允许生成N取代的DKP。本文描述了这种方法的通用性,其以高光学纯度生产用于材料和药物发现的支架。
    DOI:
    10.1002/adsc.202000470
  • 作为产物:
    参考文献:
    名称:
    Enantiomerically pure piperazines via NaBH4/I2 reduction of cyclic amides
    摘要:
    Enantiomerically pure (3S,7R,8aS)-3-phenyloctahydropyrrolo[1,2-a]pyrazine-7-ol, (3S,7R,8aS)-3-methyl octahydropyrrolo[1,2-a]pyrazine-7-ol, (3S,7R,8aS)-3-isopropyloctahydropyrrolo[1,2-a]pyrazine-7-ol and (35,7R,8aS)-3-isobutyloctahydropyrrolo[1,2-a]pyrazine-7-ol 16d were synthesized via preparation of the corresponding cyclic amides from enantiomerically pure L-proline and hydroxyproline derivatives followed by reduction using sodium borohydride-iodine. (C) 2016 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2016.12.002
点击查看最新优质反应信息

文献信息

  • Conversion of “Customizable Units” into<i>N</i>-Alkyl Amino Acids and Generation of<i>N</i>-Alkyl Peptides
    作者:Carlos J. Saavedra、Carmen Carro、Dácil Hernández、Alicia Boto
    DOI:10.1021/acs.joc.9b00114
    日期:2019.7.5
    An efficient conversion of hydroxyproline “customizable” units into new amino acids with a variety of N-alkyl substituents is described. The process is versatile and can afford valuable N-methyl amino acids and N,O-acetals. In addition, it allows the introduction of N-homoallylic substituents and N-chains with terminal ester, ketone, or cyano groups. These chains could be used for peptide extension
    描述了羟脯酸“可定制”单元到具有各种N-烷基取代基的新氨基酸的有效转化。该方法是通用的,并且可以提供有价值的N-甲基氨基酸和N,O-乙缩醛。另外,它允许引入具有末端酯,酮或基的N-均烯丙基取代基和N-链。这些链可用于肽延伸或与其他分子的缀合(例如,通过烯烃复分解,肽连接等)。仅需两个步骤(对于R = CH 2 OAc)或三个步骤(裂解吡咯烷环,操纵α链和N-取代基)在无属的温和条件下提供高光学纯度的产品。
  • Structural Diversity using Hyp <i>“Customizable Units”</i> : <i>Proof‐of‐Concept</i> Synthesis of Sansalvamide‐Related Antitumoral Peptides
    作者:Fernando Cuevas、Carlos J. Saavedra、Ivan Romero‐Estudillo、Alicia Boto、Mario Ordóñez、Irene Vergara
    DOI:10.1002/ejoc.202001427
    日期:2021.2.12
    create structural diversity for biological screenings is highlighted in this proof‐of‐concept synthesis of new peptides related to the potent antitumoral Sansalvamide A. The selective modification of a parent peptide with a customizable Hyp unit rapidly afforded differently N1‐substituted linear and cyclic peptides. Hits with promising activity against MCF7 breast cancer line were detected therefrom.
    在概念验证中,与有效的抗肿瘤Sansalvamide A相关的新肽的合成突显了“可定制单位”为生物学筛选创造结构多样性的潜力。用可定制Hyp单位对母体肽进行的选择性修饰迅速提供了不同的结果N1取代的线性和环状肽。从中检测到对MCF7乳腺癌细胞具有有希望的活性的命中。
  • Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors
    作者:Jie Zhang、Qiang Wang、Hao Fang、Wenfang Xu、Ailin Liu、Guanhua Du
    DOI:10.1016/j.bmc.2007.01.020
    日期:2007.4
    A series of pyrrolidine derivatives were synthesized and evaluated for their ability to inhibit neuraminidase (NA) of influenza A virus (H3N2). All compounds were synthesized in good yields starting from commercially 4-hydroXy-L-proline using a suitable synthetic strategy. These compounds showed potent inhibitory activity against influenza A neuraminidase. Within this series, five compounds, 6e, 9c, 9e, 9f, and 10e, have good potency (IC50 = 1.56-2.71 mu M) which are compared to that the NA inhibitor Oseltarnivir (IC50 = 1.06 mu M), and could be used as lead compoundS in the future. (c) 2007 Elsevier Ltd. All rights reserved.
  • Attenuation of TNF-α secretion by l-proline-based cyclic dipeptides produced by culture broth of Pseudomonas aeruginosa
    作者:Rukaiyya Khan、Ameer Basha、Ragavendra Goverdhanam、Poorna Chandra Rao、Yuhei Tanemura、Yoshinori Fujimoto、Ahil Sajeli Begum
    DOI:10.1016/j.bmcl.2015.10.075
    日期:2015.12
    To identify small molecule inhibitors of TNF-alpha, bioassay- and LC-MS-guided chemical investigation on EtOAc extract of Pseudomonas aeruginosa ABS-36 culture broth (EEPA) was performed, which yielded four proline-based cyclic dipeptides, cyclo(Gly-L-Pro) (1), cyclo(L-Pro-L-Phe) (2), cyclo(trans-4-hydroxy-L-Pro-L-Phe) (3) and cyclo(trans-4-hydroxy-L-Pro-L-Leu) (4). Compounds 1 and 3 exhibited potent inhibition of TNF-alpha release with IC50 values of 4.5 and 14.2 mu g/mL, respectively, while EEPA showed IC50 of 38.8 mu g/mL under lipopolysaccharide treated RAW 264.7 cell ELISA assay. Also, marked attenuation of mRNA-expression of TNF-alpha was shown by all compounds. In vivo testing in rats of EEPA and chemically synthesized 4 validated significant TNF-alpha reduction with 51% (500 mg/kg) and 79% (50 mg/kg), respectively. In addition, all compounds exhibited significant diminution of IL-1 beta and IL-6 mRNA-expression levels and NO production. All samples displayed only weak toxicity to lipopolysaccharide-induced RAW 264.7 cells. (C) 2015 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸